Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/40488
標題: Expression of 53BP1 as a cisplatin-resistant marker in patients with lung adenocarcinomas
作者: Lai, T.C.
周寬基
Chow, K.C.
Lin, T.Y.
Chiang, I.P.
Fang, H.Y.
Chen, C.Y.
Ho, S.P.
何素鵬
關鍵字: 53BP1
DNA repair
cisplatin resistance
lung adenocarcinoma
cigarette
smoking
interstrand cross-link
dna-damage
cancer cells
repair
p53
checkpoint
acetaldehyde
instability
progression
induction
期刊/報告no:: Oncology Reports, Volume 24, Issue 2, Page(s) 321-328.
摘要: DNA repair is one of the major causes of spontaneous drug and radiation resistance in patients with lung adenocarcinomas (LADC). 53BP1 is a mediator that relays signals from DNA damage sensors and activates various effectors for the DNA repair and cell survival. In this study we investigated the clinical and biological significance of 53BP1. Expression of 53BP1 was detected by immunoblotting and immunohistochemistry. Our data showed that 53BP1 was detected in 166 (75.8%) of 219 LADC patients. Expression of 53BP1 correlated with tumor stage, cigarette smoking, lymphovascular invasion and poor clinical outcome. In vitro, increased 53BP1 expression elevated drug resistance, and silencing of 53BP1 expression reduced cisplatin resistance. Our results suggest that 53BP1 expression plays an important role in cisplatin resistance and predicts the prognosis for LADC.
URI: http://hdl.handle.net/11455/40488
ISSN: 1021-335X
文章連結: http://dx.doi.org/10.3892/or_00000862
Appears in Collections:生物醫學研究所

文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.